COMBINATION DRUG THERAPIES
Combination drag therapies comprising a 5-HTZA receptor agonist and an N-methyl-D-aspartate (NMDA) receptor antagonist (e.g., nitrous oxide, ketamine, etc.) are provided. Also described are pharmaceutical compositions and methods of treating a central nervous system (CNS) disorder or a psychiatric d...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English French German |
Published |
17.07.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Combination drag therapies comprising a 5-HTZA receptor agonist and an N-methyl-D-aspartate (NMDA) receptor antagonist (e.g., nitrous oxide, ketamine, etc.) are provided. Also described are pharmaceutical compositions and methods of treating a central nervous system (CNS) disorder or a psychiatric disease using the combination drug therapy, for example, via aerosol inhalation. |
---|---|
Bibliography: | Application Number: EP20220716971 |